Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1996-11-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514409, 514414, 514415, 514323, 514422, 514427, 514469, 514470, 548408, 548465, 546201, 544154, 544373, A61K 3140, C07D20910, C07D20912, C07D20914
Patent
active
055763219
ABSTRACT:
A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1.sub.A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.
REFERENCES:
patent: 3929793 (1975-12-01), Popelak et al.
patent: 4146630 (1979-03-01), Kampe et al.
patent: 4244961 (1981-01-01), Kluge et al.
patent: 4288442 (1981-09-01), Friebe et al.
patent: 4304915 (1981-12-01), Berthold
patent: 4361562 (1982-11-01), Berthold
patent: 4460586 (1984-07-01), Berthold
patent: 4803203 (1989-02-01), Caprathe et al.
patent: 4935414 (1990-06-01), Stenzel et al.
patent: 5013761 (1991-05-01), Beedle et al.
Mutschler H., Drug Actions Basic Priniples and Therapeutic Aspects. Med Pharm Publ. (1995) pp. 309-312.
West, et al., Psychopharmacology, 104, 91-96 (1991).
Hilleman, et al., Arch. Intern. Med., 152, 350-352 (1992).
Artigas, TiPs, 14, 262 (1993).
Fuller, Life Sciences, 55, 163-167 (1994).
Jacobsen, J. Clin. Psychiatry, 52, 217-220 (1991).
Hjorth, J. Neurochem., 60, 776-779 (1993).
Artigas, et al., Arch. Gen. Psychiatry, 51, 248-251 (1994).
Hoey, et al., European J. of Pharm., 231, 477-480, (1993).
Marxer, et al., J. Org. Chem., 40, 1427-1433 (1975).
Parham, et al., J. Org. Chem., 41, 2628-2635 (1976).
Yamato, et al., J. Med. Chem., 24, 194-198 (1981).
Evans, et al., J. Med. Chem., 35, 3919-3927 (1992).
Efange, et al., J. Med. Chem., 37, 2574-2582 (1994).
Chambers, et al., J. Med. Chem., 35, 2033-2039 (1992).
Armah, et al., Br. J. Pharmacol., 96, 807-816 (1989).
Derwent Abstract, Japanese 2121-924-A.
Derwent Abstract, Japanese 2121-966-A.
Krushinski, Jr. Joseph H.
Rasmussen Kurt
Rocco Vincent P.
Schaus John M.
Thompson Dennis C.
Boone David E.
Bottino Anthony
Eli Lilly and Company
Jones Joseph A.
Shah Mukund J.
LandOfFree
Compounds having effects on serotonin-related systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having effects on serotonin-related systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having effects on serotonin-related systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541209